Capstone Investment Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,100
Closed -$270K 1712
2022
Q3
$270K Buy
1,100
+200
+22% +$54K ﹤0.01% 1409
2022
Q2
$223K Sell
900
-1,600
-64% -$432K ﹤0.01% 1400
2022
Q1
$828K Buy
2,500
+200
+9% +$61.6K ﹤0.01% 1379
2021
Q4
$826K Buy
2,300
+200
+10% +$67.6K ﹤0.01% 1358
2021
Q3
$684K Buy
2,100
+1,000
+91% +$339K ﹤0.01% 1507
2021
Q2
$343K Sell
1,100
-1,700
-61% -$522K ﹤0.01% 1441
2021
Q1
$892K Sell
2,800
-800
-22% -$256K ﹤0.01% 1160
2020
Q4
$1.17M Sell
3,600
-1,100
-23% -$304K ﹤0.01% 1032
2020
Q3
$1.3M Buy
4,700
+600
+15% +$173K 0.01% 942
2020
Q2
$990K Buy
4,100
+1,400
+52% +$281K 0.01% 921
2020
Q1
$392K Sell
2,700
-1,700
-39% -$282K 0.01% 930
2019
Q4
$751K Buy
4,400
+1,400
+47% +$260K ﹤0.01% 1067
2019
Q3
$534K Buy
3,000
+1,800
+150% +$389K ﹤0.01% 1075
2019
Q2
$313K Buy
1,200
+900
+300% +$239K ﹤0.01% 1194
2019
Q1
$86K Buy
+300
New +$99.7K ﹤0.01% 1203

Other funds holding ABMD

Capstone Investment Advisors's ABMD Position: Q4 2022 in Review

Capstone Investment Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 667 shares — an estimated $164K sold.

Capstone Investment Advisors first reported a position in ABMD in Q2 2017 and held it in 9 quarters. The position peaked at $4.57M in Q2 2017. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capstone Investment Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 667 Abiomed Inc shares in Q4 2022, an estimated $164K.
  • Capstone Investment Advisors first reported a position in Abiomed Inc in Q2 2017 and held it in 9 quarters.
  • Capstone Investment Advisors's Abiomed Inc position peaked at $4.57M in Q2 2017.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capstone Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.